Stock Information

• Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
  Fri, Feb 13, 2026 12:00 PM
• 3 Profitable Stocks We Steer Clear Of
  Fri, Feb 13, 2026 4:38 AM
• Bio-Rad Laboratories (BIO) Q4 Earnings Miss Estimates
  Thu, Feb 12, 2026 10:35 PM
• Improved Pharma Expands Pharmaceutical Development Services with New Automated Dissolution Capabilities
  Thu, Feb 12, 2026 1:25 AM
• Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q4 2025 Update
  Wed, Feb 11, 2026 10:55 PM
• Agilent Announces Cash Dividend of 25.5 Cents per Share
  Wed, Feb 11, 2026 9:15 PM
• Bloomberg's 2026 Watch List Flags 5 Ideal 'Safer' February Dividend Buys
  Wed, Feb 11, 2026 6:33 PM
• Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award
  Wed, Feb 11, 2026 1:00 PM
• Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)
  Wed, Feb 11, 2026 11:45 AM
• Agilent Technologies Says FDA Approves PD-L1 IHC 22C3 pharmDx In Identifying First-Line Patients With Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Carcinoma
  Wed, Feb 11, 2026 7:53 AM

Financial data not available